These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 16878474)

  • 41. Bat lyssavirus prophylaxis in an immunocompromised patient.
    Crome MA; McCall BJ; Selvey LA; Howard SM
    Med J Aust; 1998 Aug; 169(3):175. PubMed ID: 9734519
    [No Abstract]   [Full Text] [Related]  

  • 42. Public health risk analysis of European bat lyssavirus infection in The Netherlands.
    Takumi K; Lina PH; VAN DER Poel WH; Kramps JA; VAN DER Giessen JW
    Epidemiol Infect; 2009 Jun; 137(6):803-9. PubMed ID: 18205973
    [TBL] [Abstract][Full Text] [Related]  

  • 43. First isolation of a rabid bat infected with European bat lyssavirus in Luxembourg.
    Servat A; Herr J; Picard-Meyer E; Schley L; Harbusch C; Michaux C; Pir J; Robardet E; Engel E; Cliquet F
    Zoonoses Public Health; 2015 Feb; 62(1):7-10. PubMed ID: 24373212
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Rabies: epidemiological tendencies and control tools.
    Tordo N; Bahloul C; Jacob Y; Jallet C; Perrin P; Badrane H
    Dev Biol (Basel); 2006; 125():3-13. PubMed ID: 16878455
    [TBL] [Abstract][Full Text] [Related]  

  • 45. European bat lyssaviruses: an emerging zoonosis.
    Fooks AR; Brookes SM; Johnson N; McElhinney LM; Hutson AM
    Epidemiol Infect; 2003 Dec; 131(3):1029-39. PubMed ID: 14959767
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Case report: isolation of a European bat lyssavirus type 2a from a fatal human case of rabies encephalitis.
    Fooks AR; McElhinney LM; Pounder DJ; Finnegan CJ; Mansfield K; Johnson N; Brookes SM; Parsons G; White K; McIntyre PG; Nathwani D
    J Med Virol; 2003 Oct; 71(2):281-9. PubMed ID: 12938204
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Serological Evidence of Lyssaviruses among Bats on Southwestern Indian Ocean Islands.
    Mélade J; McCulloch S; Ramasindrazana B; Lagadec E; Turpin M; Pascalis H; Goodman SM; Markotter W; Dellagi K
    PLoS One; 2016; 11(8):e0160553. PubMed ID: 27501458
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comment on: 'Rabies and African bat lyssavirus encephalitis and its prevention'.
    Briggs DJ; Wilde H; Hemachuda T; Shantavasinkul P; Quiambao B; Sudarshan MK; Madhusudana SN
    Int J Antimicrob Agents; 2011 Feb; 37(2):182-3; author reply 183-4. PubMed ID: 21176874
    [No Abstract]   [Full Text] [Related]  

  • 49. Boosting effect of purified chick embryo cell rabies vaccine using the intradermal route in persons previously immunized by the intramuscular route or vice versa.
    Sudarshan MK; Madhusudana SN; Mahendra BJ; Narayana DH; Giri MS; Muhamuda K; Ravish HS; Venkatesh GM
    Natl Med J India; 2006; 19(4):192-4. PubMed ID: 17100105
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Rabies DNA vaccination by the intranasal route in dogs.
    Tesoro Cruz E; Hernández González R; Alonso Morales R; Aguilar-Setién A
    Dev Biol (Basel); 2006; 125():221-31. PubMed ID: 16878480
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pre-exposure rabies vaccination using purified chick embryo cell rabies vaccine intradermally is immunogenic and safe.
    Kamoltham T; Thinyounyong W; Phongchamnaphai P; Phraisuwan P; Khawplod P; Banzhoff A; Malerczyk C
    J Pediatr; 2007 Aug; 151(2):173-7. PubMed ID: 17643772
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Intradermal pre-exposure rabies immunisation in New Zealand.
    Shaw MM; Leggat PA; Williams ML
    Travel Med Infect Dis; 2006 Jan; 4(1):29-33. PubMed ID: 16887722
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Viruses and bats: rabies and Lyssavirus].
    Tordo N; Marianneau MP
    Bull Mem Acad R Med Belg; 2009; 164(1-2):7-15; discussion 15-6. PubMed ID: 19718950
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Australian bat lyssavirus infection in a captive juvenile black flying fox.
    Field H; McCall B; Barrett J
    Emerg Infect Dis; 1999; 5(3):438-40. PubMed ID: 10341182
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antibody levels against rabies among occupationally exposed individuals in a Nigerian University.
    Olugasa BO; Odeniyi AO; Adeogun AO; Adeola OA
    Vet Ital; 2010; 46(1):21-8. PubMed ID: 20391364
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of antibody responses after vaccination with two inactivated rabies vaccines.
    Minke JM; Bouvet J; Cliquet F; Wasniewski M; Guiot AL; Lemaitre L; Cariou C; Cozette V; Vergne L; Guigal PM
    Vet Microbiol; 2009 Jan; 133(3):283-6. PubMed ID: 18757142
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Is there a benefit from an early booster vaccination in the control of equine influenza?
    Heldens JG; van Loon AA; van de Zande S
    Vet J; 2007 Nov; 174(3):592-8. PubMed ID: 17560150
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pre-exposure purified vero cell rabies vaccine and concomitant routine childhood vaccinations: 5-year post-vaccination follow-up study of an infant cohort in Vietnam.
    Lang J; Feroldi E; Vien NC
    J Trop Pediatr; 2009 Feb; 55(1):26-31. PubMed ID: 18048461
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Detection of antibodies to EBLV-2 in Daubenton's bats in the UK.
    Fooks AR; Brookes SM; Healy D; Smith GC; Aegerter J; Harris SL; Jones G; Brash M; Racey P; Swift S; Mackie I; Pritchard S; Landeg F
    Vet Rec; 2004 Feb; 154(8):245-6. PubMed ID: 15005453
    [No Abstract]   [Full Text] [Related]  

  • 60. Molecular epidemiology of lyssaviruses in Eurasia.
    McElhinney LM; Marston DA; Stankov S; Tu C; Black C; Johnson N; Jiang Y; Tordo N; Müller T; Fooks AR
    Dev Biol (Basel); 2008; 131():125-31. PubMed ID: 18634471
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.